Who owns AEROVATE THERAPEUTICS INC?
- Ticker: AVTE
- CUSIP Number: 008064107
Tip: Access positions for across all investors
Analyze quarterly positions in Aerovate Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aerovate Therapeutics stock
Who bought or sold AEROVATE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 8.3M | $187M | 0% | Dec 2023 |
|
| Atlas Venture Life Science Advisors | 2.0M | $46M | 0% | Dec 2023 |
|
| Baker Bros. Advisors | 1.7M | $38M | -14% | Dec 2023 |
|
| Cormorant Asset Management | 1.2M | $27M | -22% | Dec 2023 |
|
| Frazier Life Sciences Management | 1.2M | $27M | 0% | Dec 2023 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.0M | $24M | -5% | Dec 2023 |
|
| OrbiMed Advisors | 757k | $17M | 0% | Dec 2023 |
|
| Vanguard Group | 627k | $14M | 5% | Dec 2023 |
|
| Point72 Asset Management | 442k | $10M | 100% | Dec 2023 |
|
| Octagon Capital Advisors | 404k | $9.1M | -19% | Dec 2023 |
|
| Paradigm Biocapital Advisors | 143k | $3.2M | 100% | Dec 2023 |
|
| Hudson Bay Capital Management | 103k | $2.3M | 100% | Dec 2023 |
|
| Nantahala Capital Management | 91k | $2.1M | -4% | Dec 2023 |
|
| Bank of New York Mellon | 37k | $827k | 33% | Dec 2023 |
|
| Fred Alger Management | 37k | $826k | 47% | Dec 2023 |
|
| Charles Schwab Investment Management | 30k | $669k | 0% | Dec 2023 |
|
| Bank of America Corporation | 23k | $514k | 120% | Dec 2023 |
|
| ALPS Advisors | 19k | $424k | -8% | Dec 2023 |
|
| Parkwood | 16k | $357k | -24% | Dec 2023 |
|
| Barclays | 15k | $348k | 300% | Dec 2023 |
|
| Dimensional Fund Advisors | 15k | $339k | -27% | Dec 2023 |
|
| Rhumbline Advisers | 14k | $320k | 1% | Dec 2023 |
|
| Jane Street | 13k | $297k | 100% | Dec 2023 |
|
| Alliancebernstein | 13k | $297k | 5% | Dec 2023 |
|
| UBS Group | 12k | $277k | 9% | Dec 2023 |
|
| Eventide Asset Management | 12k | $276k | 100% | Dec 2023 |
|
| Golden State Equity Partners | 11k | $246k | 3% | Dec 2023 |
|
| Two Sigma Investments | 9.8k | $221k | -17% | Dec 2023 |
|
| Hrt Financial | 9.4k | $213k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 7.5k | $169k | 1% | Dec 2023 |
|
| American International | 5.6k | $126k | 0% | Dec 2023 |
|
| MetLife Investment Advisors | 5.2k | $118k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 5.0k | $113k | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 4.3k | $97k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 3.5k | $79k | 148% | Dec 2023 |
|
| Wells Fargo & Company | 2.9k | $66k | 29% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.3k | $52k | 0% | Dec 2023 |
|
| Citigroup | 2.1k | $47k | 884% | Dec 2023 |
|
| Legal & General Group | 1.7k | $38k | -78% | Dec 2023 |
|
| Amalgamated Bank | 1.4k | $32k | -7% | Dec 2023 |
|
| Summit Investment Advisors | 772.00 | $18k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 701.00 | $16k | 0% | Dec 2023 |
|
| Fortitude Family Office | 416.00 | $12k | 0% | Mar 2024 |
|
| GAMMA Investing | 94.00 | $2.8k | 18% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Aerovate Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Sep 2023 | 53k | $724k |
| Swiss National Bank | Sep 2023 | 21k | $288k |
| Squarepoint Ops | Sep 2023 | 18k | $239k |